Skystar Bio Pharmaceutical Co. (SKBI) Reports Q2 Earnings of $0.21; Guides FY11 Revs
Tweet
Share
E-mailGet Alerts SKBI Hot Sheet
Price: $0.00 --0%
Financial Fact:
PROVISION FOR INCOME TAXES: 712.93K
Today's EPS Names:
SQZB, ARDS, MDRX, More
Financial Fact:
PROVISION FOR INCOME TAXES: 712.93K
Today's EPS Names:
SQZB, ARDS, MDRX, More
Join SI Premium – FREE
Skystar Bio Pharmaceutical Co. (NASDAQ: SKBI) reported Q2 EPS of $0.21, versus $0.33 reported last year. Revenue for the quarter came in at $9.1 million, versus $8.26 million reported last year.
Sees FY2011 revenue of $52 to $55 million.
Sees FY2011 revenue of $52 to $55 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IMF chief says global economy weathered Iran war shock well
- Gordon Haskett cuts Dick's Sporting Goods price target to $130
- Truckload stocks: Seasonal pullback a buying opportunity, says Benchmark
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
